Diverse Effects of Cilostazol on Proprotein Convertase Subtilisin/Kexin Type 9 between Obesity and Non-Obesity

Diverse Effects of Cilostazol on Proprotein Convertase Subtilisin/Kexin Type 9 between Obesity and Non-Obesity

Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a key role in cholesterol homeostasis. Cilostazol exerts favorable cellular and metabolic effects; however, the effect of cilostazol on the expression of PCSK9 has not been previously reported. Our study aimed to investigate the potential m...

Full description

Bibliographic Details
Main Authors: Po-Wei Chen, Shih-Ya Tseng, Hsien-Yuan Chang, Cheng-Han Lee, Ting-Hsing Chao
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:International Journal of Molecular Sciences
Subjects:
proprotein convertase subtilisin/kexin type 9
low-density lipoprotein receptor
peroxisome proliferator-activated receptor-γ
cilostazol
obesity
Online Access:https://www.mdpi.com/1422-0067/23/17/9768

Internet

https://www.mdpi.com/1422-0067/23/17/9768

Similar Items